r-ProUK: Phase III

By WIR Staff | Feb 8, 1999 | 8:00 AM GMT

In the 180-patient PROACT II Phase III study, r-ProUK significantly reduced neurological disability in patients

Read the full 153 word article

How to gain access

Continue reading with a
two-week free trial.